TipRanks
Go Ultimate55% OFF

Neuphoria Therapeutics (BNOXN) Revenue

Neuphoria Therapeutics Revenue

Revenue (ttm)
1.17M
Revenue Growth
―
P/S Ratio
264.15
Revenue/Employee
MXN 1,174,165
Employees
1
Market Cap
MXN 310.15M

Revenue Chart

Neuphoria Therapeutics Revenue - Annual

05M10M15M20M25M30M27.15M11.94M7.40M32.06K927.54K383.16K15.65M1.17M2017201820192020202120222023202420252026
Revenue History
Download to Excel
MX:BNOXN revenue history
Fiscal End DateRevenueChangeGrowth
Jun 30, 20261.17M-14.48M-92.50%
Jun 30, 202515.65M15.65M―
Jun 30, 20240.000.00―
Jun 30, 20230.00-383.16K-100.00%
Jun 30, 2022383.16K-544.39K-58.69%
Jun 30, 2021927.54K895.48K2792.97%
Jun 30, 202032.06K-7.36M-99.57%
Jun 30, 20197.40M-4.55M-38.08%
Jun 30, 201811.94M-15.20M-56.00%
Jun 30, 201727.15M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
MX:BNOXN1.17M